TY - JOUR
T1 - Effects of vitamin D 3 and calcium supplementation on serum levels of tocopherols, retinol, and specific vitamin D metabolites
AU - Chai, Weiwen
AU - Bostick, Roberd M.
AU - Ahearn, Thomas U.
AU - Franke, Adrian A.
AU - Custer, Laurie J.
AU - Cooney, Robert V.
N1 - Funding Information:
This research was supported in part by the National Institutes of Health grants R01CA104637 and R03CA132149, and Georgia Cancer Coalition Distinguished Scholar award (to Roberd M. Bostick). Weiwen Chai was supported by a postdoctoral fellowship on grant R25 CA90956.
PY - 2012/1/1
Y1 - 2012/1/1
N2 - γ-Tocopherol (γT) protects against DNA-damaging effects of nitrogen oxides, yet its physiologic regulation in vivo is unknown. Observational studies indicate inverse associations of 25[OH]-vitamin D with γT and leptin. To determine whether vitamin D 3 supplementation alters levels of lipid-soluble micronutrients, serum samples (N = 85 subjects) from a randomized, double-blind, placebo-controlled clinical trial of vitamin D 3 (800 IU) and calcium (2 g), alone and in combination, were analyzed for lipid micronutrients and specific vitamin D metabolites at baseline and after 6 mo of supplementation. Serum 25[OH]-vitaminD 3 levels increased 55% (P < 0.0001) and 48% (P = 0.0005), whereas 25[OH]-vitaminD 2 levels were lower by 48% (P = 0.26) and 21% (P = 0.36) in the vitamin D 3 and vitamin D 3 plus calcium groups, respectively. At baseline, γT levels were inversely associated with 25[OH]D (r = -0.31, P = 0.004). With vitamin D 3 plus calcium treatment, serum -tocopherol decreased 14% (P = 0.04), whereas similar changes in γT (19% lower, P = 0.14) were observed. No significant effects were observed for D 3 supplementation on leptin or retinol levels. These results are consistent with the hypothesis that vitamin D 3± calcium affects serum tocopherol and 25[OH]D 2 levels; however, studies using larger, more homogeneous populations are warranted.
AB - γ-Tocopherol (γT) protects against DNA-damaging effects of nitrogen oxides, yet its physiologic regulation in vivo is unknown. Observational studies indicate inverse associations of 25[OH]-vitamin D with γT and leptin. To determine whether vitamin D 3 supplementation alters levels of lipid-soluble micronutrients, serum samples (N = 85 subjects) from a randomized, double-blind, placebo-controlled clinical trial of vitamin D 3 (800 IU) and calcium (2 g), alone and in combination, were analyzed for lipid micronutrients and specific vitamin D metabolites at baseline and after 6 mo of supplementation. Serum 25[OH]-vitaminD 3 levels increased 55% (P < 0.0001) and 48% (P = 0.0005), whereas 25[OH]-vitaminD 2 levels were lower by 48% (P = 0.26) and 21% (P = 0.36) in the vitamin D 3 and vitamin D 3 plus calcium groups, respectively. At baseline, γT levels were inversely associated with 25[OH]D (r = -0.31, P = 0.004). With vitamin D 3 plus calcium treatment, serum -tocopherol decreased 14% (P = 0.04), whereas similar changes in γT (19% lower, P = 0.14) were observed. No significant effects were observed for D 3 supplementation on leptin or retinol levels. These results are consistent with the hypothesis that vitamin D 3± calcium affects serum tocopherol and 25[OH]D 2 levels; however, studies using larger, more homogeneous populations are warranted.
UR - http://www.scopus.com/inward/record.url?scp=84856839903&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84856839903&partnerID=8YFLogxK
U2 - 10.1080/01635581.2012.630552
DO - 10.1080/01635581.2012.630552
M3 - Article
C2 - 22149065
AN - SCOPUS:84856839903
SN - 0163-5581
VL - 64
SP - 57
EP - 64
JO - Nutrition and cancer
JF - Nutrition and cancer
IS - 1
ER -